Literature DB >> 8653899

Variability in cholesterol measurements: comparison of calculated and direct LDL cholesterol determinations.

G Schectman1, M Patsches, E A Sasse.   

Abstract

Calculated low-density lipoprotein cholesterol (LDL-C) concentrations determined from the Friedewald equation have a large intraindividual CV, in part because the calculation incorporates the variability of cholesterol, high-density lipoprotein cholesterol (HDL-C), and triglyceride measurements. We studied whether a new assay that measures LDL-C directly will reduce this variability and reduce the need for averaging serial specimens. Four blood samples were obtained 1 week apart from 35 mildly hypercholesterolemic subjects and analyzed for total cholesterol, triglycerides, and HDL-C. LDL-C was calculated by the Friedewald equation, and was also measured directly with a commercially available direct LDL-C assay. The intraindividual CV for the direct and calculated LDL-C assays were similar [CV of direct LDL-C assay (mean +/- SE): 6.8 +/- 0.5% vs calculated LDL-C: 7.3 +/- 0.6%; difference 0.44%, 95% confidence interval: -0.7-1.5%]. For both assays, at least two blood tests were required from each subject to reduce total variability of LDL-C to less than or equal to 5%. We conclude that the direct LDL-C assay did not reduce the variability in LDL-C compared with the conventional LDL-C calculation. However, it may have a specific role in lipid disorder evaluation and (or) monitoring when triglycerides are increased or the LDL-C value alone is needed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653899

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  Apolipoprotein B: a predictor of inflammatory status in postmenopausal overweight and obese women.

Authors:  M Faraj; L Messier; J P Bastard; A Tardif; A Godbout; D Prud'homme; R Rabasa-Lhoret
Journal:  Diabetologia       Date:  2006-05-03       Impact factor: 10.122

2.  The Association of Polyunsaturated Fatty Acid δ-5-Desaturase Activity with Risk Factors for Type 2 Diabetes Is Dependent on Plasma ApoB-Lipoproteins in Overweight and Obese Adults.

Authors:  Valérie Lamantia; Simon Bissonnette; Viviane Provost; Marie Devaux; Yannick Cyr; Caroline Daneault; Christine Des Rosiers; May Faraj
Journal:  J Nutr       Date:  2019-01-01       Impact factor: 4.798

3.  Low density lipoprotein delays clearance of triglyceride-rich lipoprotein by human subcutaneous adipose tissue.

Authors:  Simon Bissonnette; Huda Salem; Hanny Wassef; Nathalie Saint-Pierre; Annie Tardif; Alexis Baass; Robert Dufour; May Faraj
Journal:  J Lipid Res       Date:  2013-02-17       Impact factor: 5.922

4.  Non-HDL cholesterol shows improved accuracy for cardiovascular risk score classification compared to direct or calculated LDL cholesterol in a dyslipidemic population.

Authors:  Hendrick E van Deventer; W Greg Miller; Gary L Myers; Ikunosuke Sakurabayashi; Lorin M Bachmann; Samuel P Caudill; Andrzej Dziekonski; Selvin Edwards; Mary M Kimberly; William J Korzun; Elizabeth T Leary; Katsuyuki Nakajima; Masakazu Nakamura; Robert D Shamburek; George W Vetrovec; G Russell Warnick; Alan T Remaley
Journal:  Clin Chem       Date:  2011-01-12       Impact factor: 8.327

5.  Effect of cilnidipine on normal to marginally elevated urine albumin-creatinine ratio in asymptomatic non-diabetic hypertensive patients: an exponential decay curve analysis.

Authors:  Takaaki Nakatsu; Shinji Toyonaga; Keiichi Mashima; Yoko Yuki; Aya Nishitani; Hiroko Ogawa; Toru Miyoshi; Satoshi Hirohata; Reishi Izumi; Shozo Kusachi
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

6.  Association of serum levels of arachidonic acid and eicosapentaenoic acid with prevalence of major adverse cardiac events after acute myocardial infarction.

Authors:  Masayuki Ueeda; Takenori Doumei; Yoichi Takaya; Nobuhiko Ohnishi; Atsushi Takaishi; Satoshi Hirohata; Toru Miyoshi; Ryoko Shinohata; Shinichi Usui; Shozo Kusachi
Journal:  Heart Vessels       Date:  2010-10-21       Impact factor: 2.037

7.  Microalbuminuria in untreated prehypertension and hypertension without diabetes.

Authors:  Erhan Tenekecioglu; Mustafa Yilmaz; Osman Can Yontar; Kemal Karaagac; Fahriye Vatansever Agca; Ahmet Tutuncu; Mustafa Kuzeytemiz; Adem Bekler; Muhammed Senturk; Ufuk Aydin; Serafettin Demir
Journal:  Int J Clin Exp Med       Date:  2014-10-15

8.  Comparison of Formulas for Low-Density Lipoprotein (LDL) Calculation for Predicting the Risk of Metabolic Syndrome.

Authors:  Babak Pezeshki; Mojtaba Golrazeghi; Sayed Reza Hojati; Fatemeh Rostamian; Hadi Raeisi Shahraki; Mojtaba Farjam; Reza Homayounfar
Journal:  Galen Med J       Date:  2020-01-27

9.  Validation of the friedewald formula in patients with metabolic syndrome.

Authors:  José Knopfholz; Caio César Diniz Disserol; Andressa Jardim Pierin; Fernanda Letícia Schirr; Larissa Streisky; Lilian Lumi Takito; Patrícia Massucheto Ledesma; José Rocha Faria-Neto; Marcia Olandoski; Claudio Leinig Pereira da Cunha; Antonio Milton Bandeira
Journal:  Cholesterol       Date:  2014-02-06

10.  Racial difference in Acylation Stimulating Protein (ASP) correlates to triglyceride in non-obese and obese African American and Caucasian women.

Authors:  Thea Scantlebury-Manning; Joseph Bower; Katherine Cianflone; Hisham Barakat
Journal:  Nutr Metab (Lond)       Date:  2009-04-17       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.